Click on the buttons below to see data by different views.

https://datawrapper.dwcdn.net/5dQ3B/6/" style="background:#84aedb; padding:1px 6px; border-radius:5px; color:#ffffff; font-weight:400; box-shadow:0px 0px 7px 2px rgba(0,0,0,0.07); cursor:pointer;" rel="nofollow noopener noreferrer"> Overall

https://datawrapper.dwcdn.net/1n9EE/1/" style="background:#2c5f9e; padding:1px 6px; border-radius:5px; color:#ffffff; font-weight:400; box-shadow:0px 0px 7px 2px rgba(0,0,0,0.07); cursor:pointer;" rel="nofollow noopener noreferrer"> Sex

https://datawrapper.dwcdn.net/89EwC/2/" style="background:#2c5f9e; padding:1px 6px; border-radius:5px; color:#ffffff; font-weight:400; box-shadow:0px 0px 7px 2px rgba(0,0,0,0.07); cursor:pointer;" rel="nofollow noopener noreferrer"> Race/Ethnicities

https://datawrapper.dwcdn.net/rg0Fe/1/" style="background:#2c5f9e; padding:1px 6px; border-radius:5px; color:#ffffff; font-weight:400; box-shadow:0px 0px 7px 2px rgba(0,0,0,0.07); cursor:pointer;" rel="nofollow noopener noreferrer"> Transmission Categories

. Notes: Percent change in HIV diagnoses is based on the 2010 and 2022 data points. HIV diagnosis data in 2020 reflects the COVID-19 pandemic, which impacted testing behaviors, surveillance, and care-related services and should be interpreted with caution. 2021-2022 data may also be impacted.

The states with the highest rates of HIV diagnoses in 2022 included Georgia, Louisiana, and Florida. However, the states with the highest number of people with HIV were Texas, California, and Florida. In Texas, there were around 4,896 people diagnosed with HIV. HIV/AIDS diagnoses In 2022, there were an estimated 38,043 new HIV diagnoses in the United States, a slight increase compared to the year before. Men account for the majority of these new diagnoses. There are currently around 1.2 million people living with HIV in the United States. Deaths from HIV The death rate from HIV has decreased significantly over the past few decades. In 2023, there were only 1.3 deaths from HIV per 100,000 population, the lowest rate since the epidemic began. However, the death rate varies greatly depending on race or ethnicity, with the death rate from HIV for African Americans reaching 19.2 per 100,000 population in 2022, compared to just three deaths per 100,000 among the white population.

Click on the buttons below to see number or rate of new HIV diagnoses:

https://datawrapper.dwcdn.net/F0eZb/11/" style="background:#84aedb; padding:1px 6px; border-radius:5px; color:#ffffff; font-weight:400; box-shadow:0px 0px 7px 2px rgba(0,0,0,0.07); cursor:pointer;" rel="nofollow noopener noreferrer"> Number
https://datawrapper.dwcdn.net/QBA7r/6/" style="background:#2c5f9e; padding:1px 6px; border-radius:5px; color:#ffffff; font-weight:400; box-shadow:0px 0px 7px 2px rgba(0,0,0,0.07); cursor:pointer;" rel="nofollow noopener noreferrer"> Rate . Notes: TN and AZ both had 860 HIV diagnoses in 2022 and tied for the 10th place in ranking. The subtotal reflects the diagnoses in both states (860 Dx each or 1720 in total).

In 2022, the District of Columbia had the highest HIV disease death rate among all U.S. states where 6.2 out of 100,000 inhabitants died due to HIV in 2022. This statistic shows the U.S. states with the highest HIV disease death rates in 2022.

In 2022, the states with the highest number of HIV diagnoses were Texas, California, and Florida. That year, there were a total of around 37,601 HIV diagnoses in the United States. Of these, 4,896 were diagnosed in Texas. HIV infections have been decreasing globally for many years. In the year 2000, there were 2.8 million new infections worldwide, but this number had decreased to around 1.3 million new infections by 2023. The number of people living with HIV remains fairly steady, but the number of those that have died due to AIDS has reached some of its lowest peaks in a decade. Currently, there is no functional cure for HIV or AIDS, but improvements in therapies and treatments have enabled those living with HIV to have a much improved quality of life.

United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.500 % in 2014. This stayed constant from the previous number of 0.500 % for 2013. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.500 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.500 % in 2014 and a record low of 0.500 % in 2014. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted Average;

Click on the buttons below to see data by different views.

https://datawrapper.dwcdn.net/eQD5R/11/" style="background:#84aedb; padding:1px 6px; border-radius:5px; color:#ffffff; font-weight:400; box-shadow:0px 0px 7px 2px rgba(0,0,0,0.07); cursor:pointer;" rel="nofollow noopener noreferrer"> Overall

https://datawrapper.dwcdn.net/b014q/3/" style="background:#2c5f9e; padding:1px 6px; border-radius:5px; color:#ffffff; font-weight:400; box-shadow:0px 0px 7px 2px rgba(0,0,0,0.07); cursor:pointer;" rel="nofollow noopener noreferrer"> Sex

https://datawrapper.dwcdn.net/NVv8u/1/" style="background:#2c5f9e; padding:1px 6px; border-radius:5px; color:#ffffff; font-weight:400; box-shadow:0px 0px 7px 2px rgba(0,0,0,0.07); cursor:pointer;" rel="nofollow noopener noreferrer"> Transmission Categories . Notes: Percent change in HIV diagnoses is based on the 2010 and 2022 data points. HIV diagnosis data in 2020 reflects the COVID-19 pandemic, which impacted testing behaviors, surveillance, and care-related services and should be interpreted with caution. 2021-2022 data may also be impacted.

In 2023, Black or African Americans had the highest rates of HIV diagnoses among males in the United States. In that year, among all men, 19 per 100,000 were diagnosed with HIV. This statistic displays the rate of HIV diagnoses among males in the U.S. in 2023, by race and ethnicity (per 100,000 population).

Click on the buttons below to see data by different views.

https://datawrapper.dwcdn.net/V1xTJ/3/" style="background:#84aedb; padding:1px 6px; border-radius:5px; color:#ffffff; font-weight:400; box-shadow:0px 0px 7px 2px rgba(0,0,0,0.07); cursor:pointer;" rel="nofollow noopener noreferrer"> Overall

https://datawrapper.dwcdn.net/iqFmU/1/" style="background:#2c5f9e; padding:1px 6px; border-radius:5px; color:#ffffff; font-weight:400; box-shadow:0px 0px 7px 2px rgba(0,0,0,0.07); cursor:pointer;" rel="nofollow noopener noreferrer"> Race/Ethnicity

https://datawrapper.dwcdn.net/cKq90/1/" style="background:#2c5f9e; padding:1px 6px; border-radius:5px; color:#ffffff; font-weight:400; box-shadow:0px 0px 7px 2px rgba(0,0,0,0.07); cursor:pointer;" rel="nofollow noopener noreferrer"> Transmission Categories . Notes: Percent change in HIV diagnoses is based on the 2010 and 2022 data points. HIV diagnosis data in 2020 reflects the COVID-19 pandemic, which impacted testing behaviors, surveillance, and care-related services and should be interpreted with caution. 2021-2022 data may also be impacted.

HIV/AIDS deaths in the U.S. have dropped significantly in recent years. In 1995, the death rate from HIV per 100,000 people was ****. That number has since decreased to *** per 100,000 as of 2024. The reduction in the HIV death rate in the U.S. can be attributed to an increase in access to HIV medications. HIV/AIDS in the U.S. Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) cause a systemic viral infection that damages the immune system. AIDS is a syndrome that is caused by HIV. AIDS is when the immune system is severely weakened by HIV and the body can no longer fight off infections. Among all U.S. states, Georgia, followed by Florida and Louisiana, had the highest rates of new HIV diagnoses in 2022. HIV/AIDS treatments in the U.S. HIV/AIDS treatments include antiretroviral medications to reduce the levels of HIV within the body. The largest funders for HIV/AIDS medications and research are the National Institutes of Health (NIH) and the Ryan White Program. The top HIV drug worldwide, based on revenue generated in 2023 was Biktarvy. Around the world, access to antiretroviral treatment has increased dramatically in recent years, a huge step in reducing the number of HIV-related deaths. There is currently no cure for HIV.

Notes: AIAN refers to American Indian or Alaska Native. NHPI refers to Native Hawaiian or Pacific Islander.

Among all countries worldwide those in sub-Saharan Africa have the highest rates of HIV. The countries with the highest rates of HIV include Eswatini, South Africa, and Lesotho. In 2024, Eswatini had the highest prevalence of HIV with a rate of around ** percent. Other countries, such as Zimbabwe, have significantly decreased their HIV prevalence. Community-based HIV services are considered crucial to the prevention and treatment of HIV. HIV Worldwide The human immunodeficiency virus (HIV) is a viral infection that is transmitted via exposure to infected semen, blood, vaginal and anal fluids, and breast milk. HIV destroys the human immune system, rendering the host unable to fight off secondary infections. Globally, the number of people living with HIV has generally increased over the past two decades. However, the number of HIV-related deaths has decreased significantly in recent years. Despite being a serious illness that affects millions of people, medication exists that effectively manages the progression of the virus in the body. These medications are called antiretroviral drugs. HIV Treatment Generally, global access to antiretroviral treatment has increased. However, despite being available worldwide, not all adults have access to antiretroviral drugs. There are many different antiretroviral drugs available on the market. As of 2024, ********, an antiretroviral marketed by Gilead, was the leading HIV treatment based on revenue.

Notes: Data are estimates among those ages 13 and older. Percentages may not sum to 100 due to rounding. U.S. female population data is from the U.S. Census Bureau's Annual Estimates of the Resident Population by Sex, Race, and Hispanic Origin for the United States: April 1, 2020 to July 1, 2023.

United States US: Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.110 Ratio in 2019. This stayed constant from the previous number of 0.110 Ratio for 2018. United States US: Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.120 Ratio from Dec 2010 (Median) to 2019, with 10 observations. The data reached an all-time high of 0.130 Ratio in 2012 and a record low of 0.110 Ratio in 2019. United States US: Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), uri: https://aidsinfo.unaids.org/, publisher: UNAIDS, date accessed: 2025-08-27, date published: 2025-07;Weighted average;

Prevalence of HIV, total (% of population ages 15-49) in United States was reported at 0.4 % in 2021, according to the World Bank collection of development indicators, compiled from officially recognized sources. United States - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on March of 2026.

Notes: Data are estimates among those ages 13 and older. Distribution by transmission category includes all women and girls. "Other" includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or identified. Percentage may not sum to 100% due to rounding; total percentage for those Ages 35+ do not sum to 58% as stated in the text due to rounding.

In 2024, Haiti and Suriname ranked first by HIV prevalence among adults aged 15 to 49 years among the 23 countries with a value of **** percent.

As of 2023, around 47 percent of all adults in New York had received an HIV test during their lifetime. This statistic shows the U.S. states with the highest percentage of persons who had ever received an HIV test as of 2023.

According to Cognitive Market Research, the global HIV Diagnostics market size is USD 4158.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 10.90% from 2024 to 2031. North America held the major market share for more than 40% of the global revenue with a market size of USD 1663.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031. Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1247.46 million. Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 956.39 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.9% from 2024 to 2031. Latin America had a market share of more than 5% of the global revenue with a market size of USD 207.91 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2031. Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 83.16 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.6% from 2024 to 2031. Consumables held the highest HIV Diagnostics market revenue share in 2024. Market Dynamics of HIV Diagnostics Market Key Drivers for HIV Diagnostics Market Increasing Prevalence of Sexually Transmitted Disease to Increase the Demand Globally Throughout the many decades of the HIV pandemic, the number of infected individuals is continually rising. The socioeconomic variables driving this continuous increase also suggest that preventative measures have not been successful. Even though many of these infections are preventable, there are an estimated 20 million new cases of STDs in the US each year, and the rate is still rising. Moreover, there are over 1.2 million HIV-positive individuals residing in the United States. Attempts to encourage testing and screening for sexually transmitted infections can ascertain an individual's likelihood of acquiring one and help those who already have one receive treatment, so enhancing their health and lowering the danger of HIV spreading to others. Approximately 38.4 million people worldwide were HIV positive in 2021. Among these, women and girls made up nearly 54%. Rising Initiatives by Global Agencies to Propel Market Growth HIV is among the world's most important public health concerns. As a result, there is a global commitment to stopping new HIV infections and giving everyone on the planet access to HIV therapy. WHO recommends testing for HIV to anyone who might be at risk. The World Bank was a leader in global financing for HIV/AIDS in the early phases of the pandemic and has contributed US$4.6 billion to programs related to the illness since 1989. Because of assistance from the Bank—more precisely, through the International Development Association—for 1,500 counseling and testing centers, about 7 million people have had HIV tests. Restraint Factor for the HIV Diagnostics Market Lack of Healthcare Infrastructure and Awareness to Limit the Sales A proper infrastructure for healthcare delivery is lacking in many areas, especially in poor nations, which makes it difficult to provide diagnostic services. This covers concerns with the supply chain, inadequate laboratory facilities, and skilled staff. It might be particularly difficult to access diagnostic services in rural and isolated places due to a lack of healthcare facilities and inadequate transportation infrastructure. Furthermore, HIV diagnosis rates are lower in the developing Asia-Pacific, Middle East, and African regions. These areas require a sufficient number of diagnostic facilities. Additionally, the diagnosis process needs to be explained to the majority of patients, which restricts market growth in these areas. Impact of Covid-19 on the HIV Diagnostics Market The COVID-19 pandemic has had a significant impact on the HIV diagnostics market, both in terms of challenges and opportunities. There was a decrease in HIV testing and diagnostic services during the pandemic as a result of the extensive healthcare resources being redirected to handle COVID-19. Some facilities were converted to provide COVID-19 treatment, and clinics and labs had a staffing crisis. Reduced HIV testing rates were the outcome of routine and community-based HIV testing programs being frequently halted to stop the spread of COVID-19. The adoption of telemedicine and remote healthcare services was expedited by the epidem...

In 2024, the number of diagnosed HIV cases in Mexico amounted to approximately 19,000. That year, the State of Mexico, Veracruz, and Mexico City were the federative entities with the highest number of people diagnosed with the human immunodeficiency virus (HIV), with more than 1,000 patients each. Moreover, most registered HIV cases in the Latin American country between 1984 and 2023 corresponded to men. People living with HIV in Latin America In the last few years, the number of people living with HIV in Latin America has been increasing. According to recent estimates, the number of individuals living with this condition rose from around 1.6 million in 2013 to almost 2.2 million by 2022. From a country perspective, Brazil and Mexico were the Latin American nations where most people were living with the disease, reaching approximately 990,000 and 370,000 patients, respectively. ART is more costly in Latin America HIV is commonly treated through antiretroviral therapy (ART), a drug-based treatment aimed at reducing the viral load in the blood to help control the development of the disease while improving the health of those infected. Although the share of deaths among people living with HIV due to causes unrelated to AIDS increased globally since 2010, there are still inequalities in the access to ART therapy. As of 2022, Latin America and the Caribbean recorded the highest average price per person for HIV antiretroviral therapy compared to other regions worldwide.